Risk factors for mesh/suture erosion following sacral colpopexy

Geoffrey W. Cundiff, Edward Varner, Anthony G. Visco, Halina M. Zyczynski, Charles W. Nager, Peggy A. Norton, Joseph Schaffer, Morton B. Brown, Linda Brubaker

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Objective: The purpose of this study was to identify risks for mesh/suture erosions following abdominal sacral colpopexy (ASC). Study Design: We analyzed demographic, perioperative variables, and erosion status in 322 participants in the Colpopexy and Urinary Reduction Efforts study 2 years after sacral colpopexy. Results: The predominant graft used was synthetic mesh: woven polyester (Mersilene; Ethicon, Inc, Somerville, NJ) (42%) or polypropylene (48%). Twenty subjects (6%) experienced mesh/suture erosion. Unadjusted risk factors for mesh/suture erosion were expanded polytrafluroethylene (ePTFE) mesh (ePTFE 4/21 [19%] vs non-ePTFE 16/301 [5%]; odds ratio [OR], 4.2), concurrent hysterectomy (OR, 4.9), and current smoking (OR, 5.2). Of those with mesh erosion, most affected women (13/17) underwent at least 1 surgery for partial or total mesh removal. Two were completely resolved, 6 had persistent problems, and 5 were lost to follow-up. No resolution was documented in the 4 women who elected observation. Conclusion: Expanded PTFE mesh should not be used for sacral colpopexy. Concurrent hysterectomy and smoking are modifiable risks for mesh/suture erosion.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume199
Issue number6
DOIs
StatePublished - Dec 2008

Fingerprint

Sutures
Odds Ratio
Hysterectomy
Smoking
Polyesters
Polypropylenes
Lost to Follow-Up
Polytetrafluoroethylene
Observation
Demography
Transplants

Keywords

  • CARE trial
  • expanded polytrafluroethylene (Gore-Tex, GORE Medical, Newark, DE)
  • hysterectomy
  • mesh erosion
  • sacral colpopexy

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Cundiff, G. W., Varner, E., Visco, A. G., Zyczynski, H. M., Nager, C. W., Norton, P. A., ... Brubaker, L. (2008). Risk factors for mesh/suture erosion following sacral colpopexy. American Journal of Obstetrics and Gynecology, 199(6). https://doi.org/10.1016/j.ajog.2008.07.029

Risk factors for mesh/suture erosion following sacral colpopexy. / Cundiff, Geoffrey W.; Varner, Edward; Visco, Anthony G.; Zyczynski, Halina M.; Nager, Charles W.; Norton, Peggy A.; Schaffer, Joseph; Brown, Morton B.; Brubaker, Linda.

In: American Journal of Obstetrics and Gynecology, Vol. 199, No. 6, 12.2008.

Research output: Contribution to journalArticle

Cundiff, GW, Varner, E, Visco, AG, Zyczynski, HM, Nager, CW, Norton, PA, Schaffer, J, Brown, MB & Brubaker, L 2008, 'Risk factors for mesh/suture erosion following sacral colpopexy', American Journal of Obstetrics and Gynecology, vol. 199, no. 6. https://doi.org/10.1016/j.ajog.2008.07.029
Cundiff, Geoffrey W. ; Varner, Edward ; Visco, Anthony G. ; Zyczynski, Halina M. ; Nager, Charles W. ; Norton, Peggy A. ; Schaffer, Joseph ; Brown, Morton B. ; Brubaker, Linda. / Risk factors for mesh/suture erosion following sacral colpopexy. In: American Journal of Obstetrics and Gynecology. 2008 ; Vol. 199, No. 6.
@article{b49a15896b074f6088d6e90960f59ab3,
title = "Risk factors for mesh/suture erosion following sacral colpopexy",
abstract = "Objective: The purpose of this study was to identify risks for mesh/suture erosions following abdominal sacral colpopexy (ASC). Study Design: We analyzed demographic, perioperative variables, and erosion status in 322 participants in the Colpopexy and Urinary Reduction Efforts study 2 years after sacral colpopexy. Results: The predominant graft used was synthetic mesh: woven polyester (Mersilene; Ethicon, Inc, Somerville, NJ) (42{\%}) or polypropylene (48{\%}). Twenty subjects (6{\%}) experienced mesh/suture erosion. Unadjusted risk factors for mesh/suture erosion were expanded polytrafluroethylene (ePTFE) mesh (ePTFE 4/21 [19{\%}] vs non-ePTFE 16/301 [5{\%}]; odds ratio [OR], 4.2), concurrent hysterectomy (OR, 4.9), and current smoking (OR, 5.2). Of those with mesh erosion, most affected women (13/17) underwent at least 1 surgery for partial or total mesh removal. Two were completely resolved, 6 had persistent problems, and 5 were lost to follow-up. No resolution was documented in the 4 women who elected observation. Conclusion: Expanded PTFE mesh should not be used for sacral colpopexy. Concurrent hysterectomy and smoking are modifiable risks for mesh/suture erosion.",
keywords = "CARE trial, expanded polytrafluroethylene (Gore-Tex, GORE Medical, Newark, DE), hysterectomy, mesh erosion, sacral colpopexy",
author = "Cundiff, {Geoffrey W.} and Edward Varner and Visco, {Anthony G.} and Zyczynski, {Halina M.} and Nager, {Charles W.} and Norton, {Peggy A.} and Joseph Schaffer and Brown, {Morton B.} and Linda Brubaker",
year = "2008",
month = "12",
doi = "10.1016/j.ajog.2008.07.029",
language = "English (US)",
volume = "199",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Risk factors for mesh/suture erosion following sacral colpopexy

AU - Cundiff, Geoffrey W.

AU - Varner, Edward

AU - Visco, Anthony G.

AU - Zyczynski, Halina M.

AU - Nager, Charles W.

AU - Norton, Peggy A.

AU - Schaffer, Joseph

AU - Brown, Morton B.

AU - Brubaker, Linda

PY - 2008/12

Y1 - 2008/12

N2 - Objective: The purpose of this study was to identify risks for mesh/suture erosions following abdominal sacral colpopexy (ASC). Study Design: We analyzed demographic, perioperative variables, and erosion status in 322 participants in the Colpopexy and Urinary Reduction Efforts study 2 years after sacral colpopexy. Results: The predominant graft used was synthetic mesh: woven polyester (Mersilene; Ethicon, Inc, Somerville, NJ) (42%) or polypropylene (48%). Twenty subjects (6%) experienced mesh/suture erosion. Unadjusted risk factors for mesh/suture erosion were expanded polytrafluroethylene (ePTFE) mesh (ePTFE 4/21 [19%] vs non-ePTFE 16/301 [5%]; odds ratio [OR], 4.2), concurrent hysterectomy (OR, 4.9), and current smoking (OR, 5.2). Of those with mesh erosion, most affected women (13/17) underwent at least 1 surgery for partial or total mesh removal. Two were completely resolved, 6 had persistent problems, and 5 were lost to follow-up. No resolution was documented in the 4 women who elected observation. Conclusion: Expanded PTFE mesh should not be used for sacral colpopexy. Concurrent hysterectomy and smoking are modifiable risks for mesh/suture erosion.

AB - Objective: The purpose of this study was to identify risks for mesh/suture erosions following abdominal sacral colpopexy (ASC). Study Design: We analyzed demographic, perioperative variables, and erosion status in 322 participants in the Colpopexy and Urinary Reduction Efforts study 2 years after sacral colpopexy. Results: The predominant graft used was synthetic mesh: woven polyester (Mersilene; Ethicon, Inc, Somerville, NJ) (42%) or polypropylene (48%). Twenty subjects (6%) experienced mesh/suture erosion. Unadjusted risk factors for mesh/suture erosion were expanded polytrafluroethylene (ePTFE) mesh (ePTFE 4/21 [19%] vs non-ePTFE 16/301 [5%]; odds ratio [OR], 4.2), concurrent hysterectomy (OR, 4.9), and current smoking (OR, 5.2). Of those with mesh erosion, most affected women (13/17) underwent at least 1 surgery for partial or total mesh removal. Two were completely resolved, 6 had persistent problems, and 5 were lost to follow-up. No resolution was documented in the 4 women who elected observation. Conclusion: Expanded PTFE mesh should not be used for sacral colpopexy. Concurrent hysterectomy and smoking are modifiable risks for mesh/suture erosion.

KW - CARE trial

KW - expanded polytrafluroethylene (Gore-Tex, GORE Medical, Newark, DE)

KW - hysterectomy

KW - mesh erosion

KW - sacral colpopexy

UR - http://www.scopus.com/inward/record.url?scp=57149146984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57149146984&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2008.07.029

DO - 10.1016/j.ajog.2008.07.029

M3 - Article

VL - 199

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -